Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 25.58 as of Saturday, July 25, 2026.
Forward PE Ratio (25.58) = Close Price ($38.75) / Consensus Forward EPS ($1.51)
FORWARD PE RATIO
25.58
SECTOR MEDIAN · HEALTHCARE
18.38
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+39.14%
vs the sector median at left
Medline Inc.
Market Cap
$32.77B
Forward PE Ratio
25.58
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Medline Inc. (MDLN) | $32.77B | 25.58 |
| Zoetis Inc. (ZTS)vs › | $31.59B | 10.95 |
| Centene Corp. (CNC)vs › | $31.31B | 18.05 |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 16.24 |
| Biogen Inc. (BIIB)vs › | $29.85B | 15.59 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 36.49 |
| ResMed Inc. (RMD)vs › | $28.33B | 17.55 |
| DexCom, Inc. (DXCM)vs › | $27.61B | 27.58 |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 12.41 |
| Mettler-Toledo International Inc. (MTD)vs › | $26.82B | 28.44 |
Trailing P/E
32.0
reported TTM EPS
Forward P/E
25.6
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $1.51 implies +24.8% EPS growth vs the reported trailing $1.21.
At today's $38.75 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.51 | $1.45 – $1.56 | 14 | 25.6x |
| 2027-12-31 | $1.66 | $1.59 – $1.70 | 15 | 23.4x |
| 2028-12-31 | $1.86 | $1.65 – $2.09 | 9 | 20.8x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
